Cargando…

Alteration of Antithrombin III and D-dimer Levels in Clinically Localized Prostate Cancer

PURPOSE: We performed a comparative analysis of the plasma levels of antithrombin (AT) III, plasminogen, fibrinogen, and D-dimer among patients with and without clinically localized prostate cancer to investigate the clinical significance of the coagulation profile in prostate cancer. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Sung Kyu, Ko, Dong Woo, Park, Juhyun, Kim, In Sung, Doo, Seung Hwan, Yoon, Cheol Yong, Park, Hongzoo, Lee, Won Ki, Kim, Dae Sung, Jeong, Seong Jin, Byun, Seok-Soo, Lee, Sang Eun
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855465/ https://www.ncbi.nlm.nih.gov/pubmed/20414406 http://dx.doi.org/10.4111/kju.2010.51.1.25

Ejemplares similares

Effect of High-dose Antithrombin Supplementation in Patients with Septic Shock and Disseminated Intravascular Coagulation
por: Kim, Youn-Jung, et al.
Publicado: (2019)

Efficacy of Serum Antithrombin III Test in Patients With Severe Traumatic Brain Injury
por: Noh, HeeSeung, et al.
Publicado: (2023)

Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)

Comparison of Functional and Cosmetic Outcomes According to Fracture Level in Gartland Type III Pediatric Supracondylar Humerus Fractures
por: Park, Moon Seok, et al.
Publicado: (2023)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Antithrombin III and D-dimer levels as indicators of disease severity in patients with hyperlipidaemic or biliary acute pancreatitis
por: Yang, Ning, et al.
Publicado: (2017)

Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy
por: Song, In-Sung, et al.
Publicado: (2011)

Prospective Analysis on the Relation between Pain and Prostate Volume during Transrectal Prostate Biopsy
por: Yun, Tae Jin, et al.
Publicado: (2007)

Simultaneous robotic low anterior resection and prostatectomy for adenocarcinoma of rectum and prostate: initial case report
por: Park, Myungchan, et al.
Publicado: (2016)

Low Preoperative Antithrombin III Level Is Associated with Postoperative Acute Kidney Injury after Liver Transplantation
por: Kim, Kyoung-Sun, et al.
Publicado: (2021)

Classification of Focal Prostatic Lesions on Transrectal Ultrasound (TRUS) and the Accuracy of TRUS to Diagnose Prostate Cancer
por: Lee, Ho Yun, et al.
Publicado: (2009)

Inhibition of HCV by the serpin antithrombin III
por: Asmal, Mohammed, et al.
Publicado: (2012)

Proper diagnosis of antithrombin III deficiency
por: Özdemir, Zehra Narlı, et al.
Publicado: (2017)

A comparison of the survival outcomes of robotic-assisted radical prostatectomy and radiation therapy in patients over 75 years old with non-metastatic prostate cancer: A Korean multicenter study
por: Ko, Young Hwii, et al.
Publicado: (2021)

Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
por: Chung, Jae Sik, et al.
Publicado: (2023)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)

Chronic Lower Urinary Tract Symptoms in Young Men Without Symptoms of Chronic Prostatitis: Urodynamic Analyses in 308 Men Aged 50 Years or Younger
por: Jeong, Seong Jin, et al.
Publicado: (2014)

Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy
por: Kim, Ki Bom, et al.
Publicado: (2015)

Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000)

Deficiency Of Antithrombin III (AT III) - Case Report and Review of the Literature
por: GĂMAN, AMELIA MARIA, et al.
Publicado: (2014)

Comparison of systematic randomized 12-core transrectal ultrasonography-guided prostate biopsy with magnetic resonance imaging-transrectal ultrasonography fusion-targeted prostate biopsy
por: Song, Byeongdo, et al.
Publicado: (2022)

Focal lesion at the midline of the prostate on transrectal ultrasonography: take it or leave it?
por: Kim, Junwoo, et al.
Publicado: (2017)

Detection of recurrence sites using (18)F-fluorocholine PET/CT in prostate cancer patients with PSA failure
por: Kim, Dong-Yun, et al.
Publicado: (2023)

Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy
por: Kim, Dowook, et al.
Publicado: (2021)

Do additional cores from cancer-suspicious lesions on transrectal ultrasound improve prostate cancer detection including index tumors over 12-core systematic biopsy?
por: Jo, Jung Ki, et al.
Publicado: (2018)

Limited Expression of Cytochrome P450 17α-Hydroxylase/17,20-Lyase in Prostate Cancer Cell Lines
por: Jeong, Chang Wook, et al.
Publicado: (2011)

Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
por: Park, Hongzoo, et al.
Publicado: (2020)

Testosterone Replacement Therapy in Men with Untreated or Treated Prostate Cancer: Do We Have Enough Evidences?
por: Kim, Myong, et al.
Publicado: (2021)

Clinical Value of Core Length in Contemporary Multicore Prostate Biopsy
por: Lee, Sangchul, et al.
Publicado: (2015)

Diagnostic Performance of %[-2]proPSA and Prostate Health Index for Prostate Cancer: Prospective, Multi-institutional Study
por: Park, Hongzoo, et al.
Publicado: (2018)

Preoperative erectile function and the pathologic features of prostate cancer
por: Jeong, Chang Wook, et al.
Publicado: (2015)

The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance
por: Jeong, Chang Wook, et al.
Publicado: (2014)

Specific deactivation of monocyte and lymphocyte migration by antithrombin III
por: Reinisch, C, et al.
Publicado: (2001)

Strategy for Cardiovascular Surgery in Patients with Antithrombin III Deficiency
por: Nishimura, Yoshiyuki, et al.
Publicado: (2018)

Antithrombin III Protects Against Contrast-Induced Nephropathy
por: Lu, Zeyuan, et al.
Publicado: (2017)

Effect of Immobilized Antithrombin III on the Thromboresistance of Polycarbonate Urethane
por: Lukas, Karin, et al.
Publicado: (2017)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Comparison of Accuracies between Real-Time Nonrigid and Rigid Registration in the MRI–US Fusion Biopsy of the Prostate
por: Hwang, Sung Il, et al.
Publicado: (2021)

Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens
por: Kim, Hwanik, et al.
Publicado: (2021)

Prediction of unilateral prostate cancer by the combination of transrectal ultrasonography-guided prostate biopsy and multi-parametric magnetic resonance imaging: A real-life experience
por: Kim, Jung Jun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3mesa0j2653urb6unbnnpjl6l6